Cell and Gene Outsourcing
-
Sustainable Approaches To Oligonucleotide Manufacturing
An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.
-
Cryopreservation Best Practices For Cell & Gene Therapy Source Material
2/26/2024
Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.
-
Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats
Explore an integrated drug substance/drug product CMC strategy and technical case studies that provide insight into delivering product-specific solutions and enabling the acceleration of novel molecular formats.
-
Optimizing Monoclonal Antibody Manufacturing For Commercial Success
Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.
-
AAV Analytics: Key Considerations When Developing A Clinical Program
4/25/2024
Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.
-
Building A Strong Safety Culture In The Biopharmaceutical Industry
1/25/2025
Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.
-
How To Apply Quality By Design Principles To Cell And Gene Therapy Release Testing
3/21/2024
Review how to develop and use QC assays that can facilitate both product and process understanding and control.
-
Quality Agreements: Defining Governance In CDMO Partnerships
5/15/2024
Quality agreements serve a critical role within a CDMO-Sponsor partnership. Review the importance of aligning objectives, quality standards, and compliance frameworks to establish a robust foundation.
-
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service
11/17/2021
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
-
Meeting Needs And Exceeding Expectations Worldwide
10/16/2024
Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.